LABORATORIOS FARMACEUTICOS ROVI, S.A. «...678910...» Page 8 out of 18 10/04/2023 15:54 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements Liquidity contract: transactions conducted in the first quarter of 2023 Register number: 21815 21/02/2023 08:03 LABORATORIOS FARMACEUTICOS ROVI, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2022 Register number: 20529 21/02/2023 08:02 LABORATORIOS FARMACEUTICOS ROVI, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2022 Register number: 20528 21/02/2023 07:58 LABORATORIOS FARMACEUTICOS ROVI, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del segundo semestre de 2022 Register number: 20526 21/02/2023 07:57 LABORATORIOS FARMACEUTICOS ROVI, S.A. Annual financial reports and audit reports La sociedad remite el Informe Financiero Anual del ejercicio 2022 Register number: 20525 16/02/2023 08:31 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company informs on the evaluation process to obtain marketing authorisation for Risvan® Register number: 20446 09/01/2023 12:03 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements Liquidity contract: transactions conducted in the fourth quarter of 2022 Register number: 19931 15/12/2022 08:18 LABORATORIOS FARMACEUTICOS ROVI, S.A. On corporate governance The Company informs about changes in the Board of Directors and the creation of an Advisory Committee. Register number: 19628 04/10/2022 12:10 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company has signed a joint venture agreement with Càrniques Ceirà and Grupo Costa to construct a plant for the production of compounds of high technological value. Register number: 18544 03/10/2022 17:42 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements Liquidity contract: transactions conducted in the third quarter of 2022 Register number: 18526 Page 8 out of 18 «...678910...»